Company profile SYRS
After 39 days of this quarter the interest is at 52.0. Based on that we can calculate that during remaining 52 days it will total up to 121.0. Syros Pharmaceuticals expected interest is significantly lower compared to previous quarter (-72.6%) and same quarter last year (-65.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 60 | 95 58.3% QoQ | 129 35.8% QoQ | 356 176.0% QoQ |
| 2020 | 355 491.7% YoY -0.3% QoQ | 150 57.9% YoY -57.7% QoQ | 230 78.3% YoY 53.3% QoQ | 192 -46.1% YoY -16.5% QoQ |
| 2021 | 276 -22.3% YoY 43.8% QoQ | 329 119.3% YoY 19.2% QoQ | 94 -59.1% YoY -71.4% QoQ | 146 -24.0% YoY 55.3% QoQ |
| 2022 | 257 -6.9% YoY 76.0% QoQ | 276 -16.1% YoY 7.4% QoQ | 277 194.7% YoY 0.4% QoQ | 415 184.2% YoY 49.8% QoQ |
| 2023 | 347 35.0% YoY -16.4% QoQ | 174 -37.0% YoY -49.9% QoQ | 200 -27.8% YoY 14.9% QoQ | 442 6.5% YoY 121.0% QoQ |
| 2024 | 52 -85.0% YoY -88.2% QoQ | - | - | - |
The average 5 years interest of Syros Pharmaceuticals was 18.59 per week. The last year interest of Syros Pharmaceuticals compared to the last 5 years has changed by 14.63%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 50.6%.
There is not enough data for Syros Pharmaceuticals stock price to provide analysis
There is not enough data for Syros Pharmaceuticals stock price to provide correlation calculation
There is not enough data for Syros Pharmaceuticals stock price to provide analysis
There is not enough data for Syros Pharmaceuticals news to provide analysis
There is not enough data for Syros Pharmaceuticals news to provide correlation calculation
There is not enough data for Syros Pharmaceuticals news to provide analysis
There is not enough data for Syros Pharmaceuticals clinical trials to provide analysis
There is not enough data for Syros Pharmaceuticals clinical trials to provide correlation calculation
There is not enough data for Syros Pharmaceuticals clinical trials to provide analysis
There is not enough data for Tamibarotene treatment to provide analysis
There is not enough data for Tamibarotene treatment to provide correlation calculation
There is not enough data for Tamibarotene treatment to provide analysis
There is not enough data for SY-2101 acute promyelocytic leukemia to provide analysis
There is not enough data for SY-2101 acute promyelocytic leukemia to provide correlation calculation
There is not enough data for SY-2101 acute promyelocytic leukemia to provide analysis
There is not enough data for SY-5609 cyclin-dependent kinase 7 inhibitor to provide analysis
There is not enough data for SY-5609 cyclin-dependent kinase 7 inhibitor to provide correlation calculation
There is not enough data for SY-5609 cyclin-dependent kinase 7 inhibitor to provide analysis
There is not enough data for Syros Pharmaceuticals headquarters to provide analysis
There is not enough data for Syros Pharmaceuticals headquarters to provide correlation calculation
There is not enough data for Syros Pharmaceuticals headquarters to provide analysis
There is not enough data for Syros Pharmaceuticals contact to provide analysis
There is not enough data for Syros Pharmaceuticals contact to provide correlation calculation
There is not enough data for Syros Pharmaceuticals contact to provide analysis